Acasti Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Acasti Pharma's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 23% to $14,249,000. The net income raised on -$64,915,000 and profit margin reached -456%. Total operating expenses were $12,665,000.
Profit Margin
| 2017 | 0 | -12.72M | |
|---|---|---|---|
| 2018 | 7.62M | -16.23M | -212.83% |
| 2019 | 11.94M | -43.03M | -360.38% |
| 2020 | 19.58M | -44.08M | -225.09% |
| 2021 | 18.44M | -75.66M | -410.15% |
| 2022 | 14.24M | -64.91M | -455.58% |
ACST.V Income Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 14.24M | 18.44M | 19.58M | 11.94M | 7.62M | 0 |
Cost of revenue | 67.21M | 80.94M | 53.13M | 46.31M | 21.96M | 9.77M |
Gross profit | -52.96M | -62.49M | -33.54M | -34.37M | -14.33M | -9.77M |
Operating exp. | ||||||
Research and development | 68.64M | 82.85M | 54.78M | 46.31M | 21.96M | 9.77M |
Selling and marketing | 1.64M | 2.11M | 2.03M | 0 | 0 | 0 |
Total operating expenses | 12.66M | 12.29M | 10.14M | 9.37M | 1.09M | 2.34M |
Operating income | -73.15M | -81.67M | -53.28M | -51.08M | -21.18M | -14.15M |
Other income (expenses), net | 8.47M | 6.01M | 9.20M | 8.04M | 4.96M | 1.43M |
Income before tax | -64.68M | -75.66M | -44.08M | -43.03M | -16.21M | -12.71M |
Income tax expense | 230K | 1K | 0 | 0 | 24K | 4K |
Net income | -64.91M | -75.66M | -44.08M | -43.03M | -16.23M | -12.72M |
Earnings per share | ||||||
Basic EPS | -0.99 | -2.3 | -1.69 | -2.41 | -17.76 | -13.95 |
Diluted EPS | -0.99 | -2.3 | -1.69 | -2.41 | -17.76 | -13.95 |